[
  {
    "Company": "Hesperos",
    "Model": "Heart–Liver (2-Organ)",
    "Organs/Tissues": "Cardiac + Liver in shared circuit",
    "Physiological/Pathological": "Physiological PK/PD or metabolite cardiotoxicity",
    "Cell Source": "hiPSC cardiomyocytes + human hepatocytes (primary/iPSC)",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "No",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "Yes",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Yes (cardiac on cantilever, liver 3D)",
    "Notable Features": "Pumpless flow, measure contractile force & electrophys",
    "Plate/Format (Throughput)": "Custom chip, low. Hesperos service",
    "Max Culture Duration": "Up to 28 days",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Limited",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "Yes (cardiac FP)",
    "Readouts - Integrated Biosensors": "Contractile force sensors",
    "Dead Volume": "Minimal",
    "Perfused": "Yes (gravity-based)",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Drug dosing, real-time heart function",
    "model_availability": "Service"
  },
  {
    "Company": "Hesperos",
    "Model": "Heart–Liver–Cancer (3-Organ)",
    "Organs/Tissues": "Cardiac + Liver + Tumor in circuit",
    "Physiological/Pathological": "Normal heart/liver + pathological tumor (chemotherapy tests)",
    "Cell Source": "hiPSC cardiomyocytes, hepatocytes, tumor cells",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "No or minimal (unless tumor stroma added)",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "Yes",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Yes (cardiac + hepatic + tumor spheroids)",
    "Notable Features": "Chemo efficacy vs. off-target toxicity measured together",
    "Plate/Format (Throughput)": "Custom multi-chamber chip, low throughput",
    "Max Culture Duration": "1–4 weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes, endpoint",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "Yes (cardiac signals)",
    "Readouts - Integrated Biosensors": "Force sensors for heart",
    "Dead Volume": "Low",
    "Perfused": "Yes, pumpless recirculation",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Combo drug dosing, track tumor & heart-liver",
    "model_availability": "Service"
  },
  {
    "Company": "Hesperos",
    "Model": "Heart–Liver–Neuron–Muscle (4-Organ)",
    "Organs/Tissues": "Cardiac, hepatic, peripheral neurons, skeletal muscle",
    "Physiological/Pathological": "Both – normal or disease (ALS) if patient iPSC used",
    "Cell Source": "hiPSC cardiomyocytes, iPSC motor neurons, muscle myotubes, hepatocytes",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "No standard",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "Yes",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes",
    "3D Scaffold": "Yes (cardiac & muscle on cantilevers, liver 3D, neuronal channels)",
    "Notable Features": "Simultaneous readouts: heart contraction, neuron firing, muscle twitch, liver function",
    "Plate/Format (Throughput)": "Custom 4-chamber chip, low. Service-based",
    "Max Culture Duration": "Up to 4 weeks",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Yes",
    "Readouts - Cell Retrieval": "Yes at endpoint",
    "Readouts - Whole Tissue": "Yes",
    "Readouts - TEER": "No",
    "Readouts - MEA": "Yes (neurons, cardiomyocytes)",
    "Readouts - Integrated Biosensors": "Force sensors for muscle/heart",
    "Dead Volume": "Low",
    "Perfused": "Yes, gravity circuit",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Add compounds, measure functional signals",
    "model_availability": "Service"
  },
  {
    "Company": "Hesperos",
    "Model": "Neuromuscular Junction (NMJ) Model",
    "Organs/Tissues": "Motor neurons + skeletal muscle with functional synapses",
    "Physiological/Pathological": "Both – normal NMJ or ALS-like (patient iPSC neurons)",
    "Cell Source": "iPSC-derived motor neurons + iPSC/primary muscle myotubes",
    "Multiple Cell Types": "Yes",
    "Stromal Cells": "No",
    "Tissue-resident Immune": "No",
    "Circulating Immune": "No",
    "Crosstalk (Multi-tissue)": "Yes (neuron-muscle synapses)",
    "Air-Liquid Interface": "No",
    "Extracellular Matrix": "Yes (microtunnels, muscle in ECM)",
    "3D Scaffold": "Yes, specialized NMJ microchannel design",
    "Notable Features": "Functional NMJ, measure contraction & synaptic blockade",
    "Plate/Format (Throughput)": "2-chamber microdevice, low throughput, service-based",
    "Max Culture Duration": "Days–weeks (ALS studies)",
    "Readouts - Live Imaging": "Yes",
    "Readouts - Supernatant Sampling": "Limited use",
    "Readouts - Cell Retrieval": "Possible endpoint",
    "Readouts - Whole Tissue": "Yes, fix for immunostain (AChR)",
    "Readouts - TEER": "No",
    "Readouts - MEA": "Possible muscle/neurons",
    "Readouts - Integrated Biosensors": "No specialized sensors, track function",
    "Dead Volume": "Low",
    "Perfused": "Minimal or static, can do mild flow",
    "Gas Mix Controlled": "Incubator",
    "Real-time Microenvironment Control": "Drug additions, measure neuromuscular function",
    "model_availability": "Service"
  }
]
